Vietnam has commenced construction of its first plasma-based biopharmaceutical production plant, located in the high-tech ...

The global proteinase K market is projected to grow from US$ 27.5 million in 2023 to US$ 43.9 million by 2033, at a CAGR of 4 ...

Market growth for biopharmaceutical PAT is primarily driven by increasing biopharmaceutical production demands, stringent quality regulations, and the pursuit of process efficiency improvements.

Microbial neutralization must constantly achieve a six-log reduction threshold of Geobacillus stearothermophilus and comply ...

Korean biopharmaceutical firms Samsung Biologics, Celltrion, and Lotte Biologics will showcase their advancements at the J.P.

The nanofiber microcarriers are the first of their kind for manufacturing viral vectors used in gene therapy production, according to Cellevate. Lonza signed a long-term supply agreement to ...

Lean manufacturing – streamlining manufacturing processes to optimize productivity and reduce waste – has the potential to transform biopharmaceutical production. This webinar will explore how ...

The global insect cell lines market is on a trajectory of unprecedented growth, projected to soar to USD 3 billion by 2033 from USD 1 billion in 2023, as reported by Future Market Insights (FMI). This ...

Repligen Corporation (RGEN), a life sciences company, on Monday announced the launch of its CTech SoloVPE PLUS System, an advanced ...

This innovative solution meets the specific needs of biopharmaceutical production, particularly for high-value, low-volume products such as gene and RNA therapies, monoclonal antibodies ...